DK186389A - Fremgangsmaade til forebyggelse af aids-foraarsagende virus ved blodtransfusion - Google Patents

Fremgangsmaade til forebyggelse af aids-foraarsagende virus ved blodtransfusion

Info

Publication number
DK186389A
DK186389A DK186389A DK186389A DK186389A DK 186389 A DK186389 A DK 186389A DK 186389 A DK186389 A DK 186389A DK 186389 A DK186389 A DK 186389A DK 186389 A DK186389 A DK 186389A
Authority
DK
Denmark
Prior art keywords
aids
virus
procedures
prevention
blood transfusion
Prior art date
Application number
DK186389A
Other languages
Danish (da)
English (en)
Other versions
DK186389D0 (da
Inventor
Peter John Lewis
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK186389D0 publication Critical patent/DK186389D0/da
Publication of DK186389A publication Critical patent/DK186389A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0215—Disinfecting agents, e.g. antimicrobials for preserving living parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Environmental Sciences (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pyridine Compounds (AREA)
DK186389A 1988-04-19 1989-04-18 Fremgangsmaade til forebyggelse af aids-foraarsagende virus ved blodtransfusion DK186389A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888809177A GB8809177D0 (en) 1988-04-19 1988-04-19 Method of preventing aids transmission-resulting from blood transfusions

Publications (2)

Publication Number Publication Date
DK186389D0 DK186389D0 (da) 1989-04-18
DK186389A true DK186389A (da) 1989-10-20

Family

ID=10635415

Family Applications (1)

Application Number Title Priority Date Filing Date
DK186389A DK186389A (da) 1988-04-19 1989-04-18 Fremgangsmaade til forebyggelse af aids-foraarsagende virus ved blodtransfusion

Country Status (13)

Country Link
US (1) US5039688A (el)
EP (1) EP0338515B1 (el)
JP (1) JPH01311021A (el)
KR (1) KR890015754A (el)
AT (1) ATE80555T1 (el)
AU (1) AU613475B2 (el)
DE (1) DE68902860T2 (el)
DK (1) DK186389A (el)
ES (1) ES2055758T3 (el)
GB (1) GB8809177D0 (el)
GR (1) GR3006218T3 (el)
IE (1) IE891248L (el)
ZA (1) ZA892721B (el)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5419759A (en) * 1988-11-17 1995-05-30 Naficy; Sadeque S. Apparatus and methods for treatment of HIV infections and AIDS
US5527802A (en) * 1992-10-01 1996-06-18 Bristol-Myers Squibb Company New uses of 3-tetrazolo -5,6,7,8- substituted-pyrido (1,2-a) pyrimidin-4-ones
DE4302244A1 (de) * 1993-01-27 1994-07-28 Naturwissenschaftliches Und Me Antivirales Chemotherapeutikum mit Breitbandwirkung und dessen Verwendung
ES2078139B1 (es) * 1993-03-05 1996-08-01 Nunez Maria Rosalia Garcia Composiciones antirretrovirales que contienen compuestos iodados.
US5439899A (en) * 1993-03-10 1995-08-08 Purdue Research Foundation Cosalane and related compounds having activity against aids and aids-related infections
US5547677A (en) * 1994-05-20 1996-08-20 Novavax, Inc. Antimicrobial oil-in-water emulsions
US5549901A (en) * 1994-05-20 1996-08-27 Novavax, Inc. Antimicrobial oil-in-water emulsions
JPH10500686A (ja) * 1994-05-20 1998-01-20 ノババックス インコーポレイテッド 抗菌性水中油エマルジョン
DE4444045C2 (de) * 1994-12-10 1997-04-17 Behringwerke Ag Verfahren zur Inaktivierung von Viren mit Hilfe von Acridin oder Acridinderivaten
US6759434B2 (en) 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
AU2002367976B2 (en) * 2001-06-05 2007-06-21 The Regents Of The University Of Michigan Nanoemulsion vaccines
ATE357138T1 (de) 2001-11-21 2007-04-15 Altachem Pharma Ltd Antipathogenische zusammensetzung verwendbar in der konservierung von blut
EP1686993B1 (en) * 2003-11-07 2011-01-12 Viratox, L.L.C. Virucidal activities of a composition comprising cetylpyridinium chloride and citric acid
US20090232748A1 (en) * 2003-11-07 2009-09-17 Viratox, L.L.C. Virucidal activities of cetylpyridinium chloride
US9839685B2 (en) 2006-04-13 2017-12-12 The Regents Of The University Of Michigan Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen
US20080195023A1 (en) * 2007-02-09 2008-08-14 Daxor Corporation Blood optimization program
WO2008103416A1 (en) * 2007-02-21 2008-08-28 Capps Charles L Synergistic enhancement of calcium propionate
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0050061B2 (en) * 1980-10-06 1990-06-20 New York Blood Center, Inc. Method of reducing undesirable activities of biological and pharmaceutical products
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
ATE64854T1 (de) * 1986-05-22 1991-07-15 Atlantic Pharma Prod Zusammensetzung mit hemmender wirkung auf zumindest ein einzelliges lebewesen und/oder virus, herstellungsverfahren und anwendungen dieser zusammensetzung.
EP0315627B1 (en) * 1986-08-01 1992-08-19 RUBINSTEIN, Alan I. A method to treat blood

Also Published As

Publication number Publication date
DE68902860T2 (de) 1993-01-21
KR890015754A (ko) 1989-11-25
JPH01311021A (ja) 1989-12-15
AU3307589A (en) 1989-10-26
IE891248L (en) 1989-10-19
DK186389D0 (da) 1989-04-18
GB8809177D0 (en) 1988-05-25
AU613475B2 (en) 1991-08-01
ES2055758T3 (es) 1994-09-01
US5039688A (en) 1991-08-13
EP0338515A1 (en) 1989-10-25
EP0338515B1 (en) 1992-09-16
ZA892721B (en) 1990-03-28
ATE80555T1 (de) 1992-10-15
DE68902860D1 (de) 1992-10-22
GR3006218T3 (el) 1993-06-21

Similar Documents

Publication Publication Date Title
DK186389A (da) Fremgangsmaade til forebyggelse af aids-foraarsagende virus ved blodtransfusion
DK161361C (da) Medicinsk genstand af polyvinylchlorid, isaer blodpose
DK111387A (da) Carbostyrilderivater og salte deraf, laegemiddel indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne
IT8867588A0 (it) Siringa monouso di sicurezza
ES552985A0 (es) Procedimiento fotodinamico de inactivacion de virus
IT9021253V0 (it) Siringa di sicurezza, monouso
DK0509019T3 (da) Behandling af humane retrovirale infektioner med 2',3'-dideoxyinosin
DK304190A (da) Terapeutisk praeparat indeholdende blokeringsmidler til behandling af chocktilstande
DK447489A (da) Metode til stabilisering af blod
NO871862D0 (no) Fremgangsmaate for paavisning av aids-virusinfeksjon.
GR900100435A (en) Rediucing the spread of infection by blood handling equipment
DK226889D0 (da) Alkoholpeptidderivat samt anvendelse deraf til mindskning af blodkoagulation
NO892269D0 (no) Ikke-hyperglykosylerte hepatitt b-virus-proteiner samt ekspresjons-"kassetter" og fremgangsmaate for fremstilling avproteinene.
NO910869D0 (no) Fremgangsmaate for desinfeksjon av medisinsk avstoepningsmasse.
DK43284A (da) Vaccine til beskyttelse af dyr mod infektion med pseudorabies virus
FR2545714B1 (fr) Detecteur de gaz dans le sang
DK0456842T3 (da) Medicinske anvendelser af M-CSF
ITTO910526A1 (it) Siringa monouso di sicurezza
FR2712493B1 (fr) Utilisation de photosensibilisateurs dérivés du noyau phorbine pour la décontamination du sang infecté par des parasites et/ou des virus.
FI896159A0 (fi) Valsanordning med en undervals med hydrauliskt innerstoed.
DK365489A (da) Fremgangsmaade til diagnostisering af hiv-infektion og diagnostiseringsapparat til anvendelse ved fremgangsmaaden
CA2005365A1 (en) Medication for the treatment or prevention of hiv virus infection through passive immunization and processes for its preparation
BR7100798U (pt) Seringa hipodermica de seguranca
IT9003580A0 (it) Siringa di sicurezza
ITTO920092V0 (it) Dispositivo di connessione per apparecchiature medicali di infusione, trasfusione e simili

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment